via openai.comOpenAI launched "dots," proactive assistants built on GPT-6 Astra that keep working across long projects and everyday tasks rather than waiting for one-off prompts. Each dot gets its own cloud computer and browser, connects to more than 4,000 apps through plugins, learns a user's preferences over time, and can be reached through ChatGPT, Slack, Teams, or voice calls. The rollout starts with Pro, Business Premium, and Enterprise plans, with specialist dots being piloted inside companies and managed alongside Microsoft's Agent 365. OpenAI stresses that users stay in control through permissions, approval requirements, and progress tracking, and that sensitive actions like password changes remain with the human.
via theverge.comICANN released its latest round of top-level domain applications, 1,615 of them from 481 applicants, and the AI land grab is on. Thirteen applicants, including OpenAI and Meta, want .agent, while seven, including OpenAI, are competing for .agi, and Anthropic and Google's registry arm filed AI-related strings of their own. Applying is not the same as winning; the strings still have to clear evaluation and contention before anyone gets to sell a .agent address.
via 404media.coAccenture has told many employees it will cap company spending on Claude at $29 per person per month, a sharp cut for workers who had been running up as much as $1,000 a month in usage. Some of those heavy users are now scrambling for ways to keep the access they had. The move reflects a broader pattern of companies discovering how fast employees burn through AI tools, and it carries some irony given how hard Accenture has pushed its own clients to invest in AI.
via techspot.comUtah is launching a one-year pilot with startup Nolla Health that lets an AI examine patients and prescribe medication, making it the first state to allow this. The scope is deliberately narrow: patients with mild-to-moderate acne pay $4.99 a month, scan their face in an app, fill out a history, and the AI picks one of eight approved topical treatments. Oversight is phased, with doctors reviewing the first 100 prescriptions before they go out, the next 400 weekly after the fact, and at least 10 percent per month after that. It is a small test, but it previews how routine, low-risk care could be handed to software.